Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Julphar
US Army
McKinsey
Fuji
Colorcon
McKesson
Covington
Accenture

Generated: April 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 208105

« Back to Dashboard

NDA 208105 describes DESIPRAMINE HYDROCHLORIDE, which is a drug marketed by Actavis Totowa, Amneal Pharms Co, Ani Pharms Inc, Heritage Pharms Inc, Ingenus Pharms Llc, Mountain, Sandoz, and Usl Pharma, and is included in twenty NDAs. It is available from eleven suppliers. Additional details are available on the DESIPRAMINE HYDROCHLORIDE profile page.

The generic ingredient in DESIPRAMINE HYDROCHLORIDE is desipramine hydrochloride. There are nine drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the desipramine hydrochloride profile page.
Summary for 208105
Tradename:DESIPRAMINE HYDROCHLORIDE
Applicant:Amneal Pharms Co
Ingredient:desipramine hydrochloride
Patents:0
Therapeutic Class:Antidepressants
Formulation / Manufacturing:see details
Pharmacology for NDA: 208105
Medical Subject Heading (MeSH) Categories for 208105
Suppliers and Packaging for NDA: 208105
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DESIPRAMINE HYDROCHLORIDE desipramine hydrochloride TABLET;ORAL 208105 ANDA Amneal Pharmaceuticals LLC 69238-1053 N 69238-1053-1
DESIPRAMINE HYDROCHLORIDE desipramine hydrochloride TABLET;ORAL 208105 ANDA Amneal Pharmaceuticals LLC 69238-1053 N 69238-1053-3

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength10MG
Approval Date:Mar 17, 2016TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength25MG
Approval Date:Mar 17, 2016TE:ABRLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength50MG
Approval Date:Mar 17, 2016TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Cantor Fitzgerald
Cipla
Teva
Boehringer Ingelheim
US Department of Justice
Deloitte
Mallinckrodt
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.